Regeneron Pharmaceuticals Inc (REGN) valuation · P/E 20, rev $14.34B
Regeneron Pharmaceuticals Inc (REGN) P/E 20, rev $14.34B.
| Metric | Value |
|---|---|
| P/E | 20 |
| Market cap | $59.10B |
| Revenue | $14.34B |
| P/S | 4.1 |
| Dividend yield | 0.67% |
REGN valuation FAQ
What is REGN's P/E ratio?
Regeneron Pharmaceuticals Inc (REGN) trailing P/E is 20 on the latest cached fundamentals snapshot.
What is REGN's market cap?
Regeneron Pharmaceuticals Inc (REGN) market cap is $59.10B on the latest cached fundamentals snapshot.
What is REGN's latest revenue?
Latest cached Regeneron Pharmaceuticals Inc (REGN) revenue was $14.34B. Statements: https://lician.com/financials/regn
What is REGN's price-to-sales ratio?
Regeneron Pharmaceuticals Inc (REGN) price-to-sales (P/S) is 4.1, cached market cap $59.10B divided by revenue $14.34B.
What is REGN's dividend yield?
Regeneron Pharmaceuticals Inc (REGN) dividend yield is 0.67% on the latest cached fundamentals snapshot.
How many REGN valuation scalars are listed on this page?
This page lists 5 cached valuation scalars for Regeneron Pharmaceuticals Inc (REGN): P/E, Market cap, Revenue, P/S, and Dividend yield.
Where is REGN valuation listed?
Cached valuation multiples for Regeneron Pharmaceuticals Inc (REGN) are listed at https://lician.com/valuation/regn.
Not investment advice. Cached rows, not a live tape.